These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31153715)

  • 1. Myocardial Iron Overload in Sickle Cell Disease: A Rare But Potentially Fatal Complication of Transfusion.
    Tavares AHJ; Benites BD; Fertrin KY
    Transfus Med Rev; 2019 Jul; 33(3):170-175. PubMed ID: 31153715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
    Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac iron overload in sickle-cell disease.
    Meloni A; Puliyel M; Pepe A; Berdoukas V; Coates TD; Wood JC
    Am J Hematol; 2014 Jul; 89(7):678-83. PubMed ID: 24664847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation.
    Stanley HM; Friedman DF; Webb J; Kwiatkowski JL
    Pediatr Blood Cancer; 2016 Aug; 63(8):1414-8. PubMed ID: 27100139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
    Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions.
    Pack-Mabien A; Brown B; Herbert DE; Haynes J
    J Am Assoc Nurse Pract; 2015 Oct; 27(10):591-6. PubMed ID: 25711464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study.
    Cancado R; Watman NP; Lobo C; Chona Z; Manzur F; Traina F; Park M; Drelichman G; Zarate JP; Marfil L
    Hematology; 2018 Oct; 23(9):676-682. PubMed ID: 29663858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe cardiac iron toxicity in two adults with sickle cell disease.
    Oduor H; Minniti CP; Brofferio A; Gharib AM; Abd-Elmoniem KZ; Hsieh MM; Tisdale JF; Fitzhugh CD
    Transfusion; 2017 Mar; 57(3):700-704. PubMed ID: 28019032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How we manage iron overload in sickle cell patients.
    Coates TD; Wood JC
    Br J Haematol; 2017 Jun; 177(5):703-716. PubMed ID: 28295188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease.
    Ballas SK
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):30-6. PubMed ID: 11206959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease.
    Tsitsikas DA; Nzouakou R; Ameen V; Sirigireddy B; Amos RJ
    Eur J Haematol; 2014 Feb; 92(2):164-7. PubMed ID: 24175986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload.
    Hankins JS; Smeltzer MP; McCarville MB; Aygun B; Hillenbrand CM; Ware RE; Onciu M
    Eur J Haematol; 2010 Jul; 85(1):51-7. PubMed ID: 20374273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences and management of iron overload in sickle cell disease.
    Porter J; Garbowski M
    Hematology Am Soc Hematol Educ Program; 2013; 2013():447-56. PubMed ID: 24319218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
    Fung EB; Harmatz P; Milet M; Ballas SK; De Castro L; Hagar W; Owen W; Olivieri N; Smith-Whitley K; Darbari D; Wang W; Vichinsky E;
    Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronically transfused pediatric sickle cell patients are protected from cardiac iron overload.
    Kaushik N; Eckrich MJ; Parra D; Yang E
    Pediatr Hematol Oncol; 2012 Apr; 29(3):254-60. PubMed ID: 22303979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
    J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.
    Fung EB; Harmatz PR; Milet M; Balasa V; Ballas SK; Casella JF; Hilliard L; Kutlar A; McClain KL; Olivieri NF; Porter JB; Vichinsky EP;
    Transfusion; 2008 Sep; 48(9):1971-80. PubMed ID: 18513257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.